- Home
- |
- About
- |
- MC-1 for PNPO Deficiency
- |
- Products
- |
- Newsroom
- |
- Investors
- |
- Contact Us
Medicure continues to closely monitor the COVID-19 pandemic and its global impact. We remain committed to our mission amidst the unprecedented public health challenge posed by COVID-19. We are focused on being a responsible and active partner in the communities where we work and live, as well as protecting the safety and well-being of our employees.
Now more than ever, we are working to ensure that patients have access to and can afford their critical Medicure medications.
In order to secure the safety of our employees to prevent the further spread of COVID-19, we are advising our commercial field team to combine working at an office and working from home. In addition,
We have an unwavering focus on delivering safe, efficacious and cost-effective medicines that benefit patients and healthcare providers. We are continuing to assess and adapt as new information becomes available.
Copyright © 2026 Medicure Inc. All Rights Reserved. | Privacy Policy | Your Privacy Choices | Cookie Preferences